Cutler Group’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,460
Closed -$57K 2438
2023
Q4
$57K Sell
1,460
-40
-3% -$1.18K 0.01% 1367
2023
Q3
$41K Sell
1,500
-400
-21% -$12.5K ﹤0.01% 1606
2023
Q2
$64K Buy
1,900
+1,200
+171% +$40.4K 0.01% 1166
2023
Q1
$25K Sell
700
-133
-16% -$5.74K ﹤0.01% 1780
2022
Q4
$37K Buy
833
+10
+1% +$357 ﹤0.01% 1774
2022
Q3
$23K Buy
+823
New +$25.2K ﹤0.01% 2499
2022
Q2
Sell
-2,100
Closed -$61K 5038
2022
Q1
$71K Sell
2,100
-5,500
-72% -$176K ﹤0.01% 1955
2021
Q4
$293K Sell
7,600
-1,900
-20% -$82.8K 0.01% 1052
2021
Q3
$512K Buy
9,500
+3,200
+51% +$150K 0.02% 774
2021
Q2
$210K Buy
+6,300
New +$173K 0.01% 1307
2018
Q1
Sell
-13
Closed 4525
2017
Q4
$0 Hold
13
﹤0.01% 4983
2017
Q3
$0 Sell
13
-20
-61% -$750 ﹤0.01% 5936
2017
Q2
$1K Sell
33
-1,260
-97% -$55.7K ﹤0.01% 5804
2017
Q1
$70K Sell
1,293
-757
-37% -$39.4K ﹤0.01% 2063
2016
Q4
$108K Sell
2,050
-87
-4% -$4.95K ﹤0.01% 1841
2016
Q3
$129K Buy
2,137
+40
+2% +$2.49K 0.01% 1602
2016
Q2
$138K Sell
2,097
-67
-3% -$4.25K 0.01% 1411
2016
Q1
$122K Sell
2,164
-1,010
-32% -$114K 0.01% 1426
2015
Q4
$746K Buy
+3,174
New +$692K 0.04% 440

Other funds holding CLDX